Bengaluru: Neutraceutical company British Biologicals inaugurated its fourth nutrition plant, its largest in South Asia, in Bengaluru on Friday. The company said the production unit is highly automated, keeping the highest quality and packaging standards as per Indian, European and US FDA guidelines. Managing director VS Reddy said, “As an innovation and research-based company in nutrition for more than two decades, we wanted to reach out to a global audience with new and unique products developed through technology-led expertise…We decided to bring the state of art facility.” tnn
We also published the following articles recently
Soon, e-commerce companies to pledge to not offer unsafe products
The consumer affairs ministry in India has set up a committee to draft a “safety pledge” that e-commerce companies must make, promising not to sell unsafe goods on their platforms. The committee, which includes representatives from major e-commerce platforms, consumer associations, and industry bodies, will submit its report in two weeks. The proposed principles of the safety pledge include detecting and preventing the sale of unsafe products, cooperating with authorities responsible for product safety, and raising consumer awareness on product safety issues.
The consumer affairs ministry in India has set up a committee to draft a “safety pledge” that e-commerce companies must make, promising not to sell unsafe goods on their platforms. The committee, which includes representatives from major e-commerce platforms, consumer associations, and industry bodies, will submit its report in two weeks. The proposed principles of the safety pledge include detecting and preventing the sale of unsafe products, cooperating with authorities responsible for product safety, and raising consumer awareness on product safety issues.
Some IT services companies gain from resale of third-party products
Infosys has seen a significant increase in revenue from the sale of software licenses and hardware, with over $1 billion generated in the 2022-23 financial year. This sets Infosys apart from its peers, as the sale of third-party products contributes more to its overall revenue. The increase is likely due to the company’s focus on large deals under CEO Salil Parekh, with a total contract value of $43 billion in the last four years. However, there are risks associated with bundled software-hardware deals, including cancellations and liability issues.
Infosys has seen a significant increase in revenue from the sale of software licenses and hardware, with over $1 billion generated in the 2022-23 financial year. This sets Infosys apart from its peers, as the sale of third-party products contributes more to its overall revenue. The increase is likely due to the company’s focus on large deals under CEO Salil Parekh, with a total contract value of $43 billion in the last four years. However, there are risks associated with bundled software-hardware deals, including cancellations and liability issues.
Some IT services companies profit from third-party product resales
Infosys has seen a significant increase in revenue from the sale of third-party software licenses and hardware, reaching over $1 billion in the 2022-23 financial year. This sets Infosys apart from its competitors, including TCS, which had lower revenue from third-party products. The increase in revenue is attributed to a rise in large deals under CEO Salil Parekh. However, there are divergent views on bundled software-hardware deals, with some experts highlighting the risks and others emphasizing the benefits for clients and service providers.
Infosys has seen a significant increase in revenue from the sale of third-party software licenses and hardware, reaching over $1 billion in the 2022-23 financial year. This sets Infosys apart from its competitors, including TCS, which had lower revenue from third-party products. The increase in revenue is attributed to a rise in large deals under CEO Salil Parekh. However, there are divergent views on bundled software-hardware deals, with some experts highlighting the risks and others emphasizing the benefits for clients and service providers.